Literature DB >> 29268487

Are specialized pro-resolving mediators promising therapeutic agents for severe bronchial asthma?

Takeshi Hisada1, Haruka Aoki-Saito1, Yasuhiko Koga1.   

Abstract

Entities:  

Year:  2017        PMID： 29268487      PMCID： PMC5720963          DOI： 10.21037/jtd.2017.10.116

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

Review 1.  Japanese guidelines for adult asthma 2017.

Authors:  Masakazu Ichinose; Hisatoshi Sugiura; Hiroyuki Nagase; Masao Yamaguchi; Hiromasa Inoue; Hironori Sagara; Jun Tamaoki; Yuji Tohda; Mitsuru Munakata; Kohei Yamauchi; Ken Ohta
Journal:  Allergol Int       Date:  2017-02-11       Impact factor: 5.836

2.  Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8+ T cells and airway hyperresponsiveness.

Authors:  Nobuaki Miyahara; Katsuyuki Takeda; Satoko Miyahara; Christian Taube; Anthony Joetham; Toshiyuki Koya; Shigeki Matsubara; Azzeddine Dakhama; Andrew M Tager; Andrew D Luster; Erwin W Gelfand
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

Review 3.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.

Authors:  Gary P Anderson
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

4.  Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness.

Authors:  Bruce D Levy; Payal Kohli; Katherine Gotlinger; Oliver Haworth; Song Hong; Shamsah Kazani; Elliot Israel; Kathleen J Haley; Charles N Serhan
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

5.  Protective effect of resolvin E1 on the development of asthmatic airway inflammation.

Authors:  Haruka Aoki; Takeshi Hisada; Tamotsu Ishizuka; Mitsuyoshi Utsugi; Akihiro Ono; Yasuhiko Koga; Noriaki Sunaga; Takashi Nakakura; Fumikazu Okajima; Kunio Dobashi; Masatomo Mori
Journal:  Biochem Biophys Res Commun       Date:  2010-08-12       Impact factor: 3.575

6.  Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.

Authors:  Oliver Haworth; Manuela Cernadas; Rong Yang; Charles N Serhan; Bruce D Levy
Journal:  Nat Immunol       Date:  2008-06-22       Impact factor: 25.606

7.  Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma.

Authors:  Jun Miyata; Koichi Fukunaga; Ryo Iwamoto; Yosuke Isobe; Kyoko Niimi; Rina Takamiya; Takahisa Takihara; Katsuyoshi Tomomatsu; Yusuke Suzuki; Tsuyoshi Oguma; Koichi Sayama; Hiroyuki Arai; Tomoko Betsuyaku; Makoto Arita; Koichiro Asano
Journal:  J Allergy Clin Immunol       Date:  2012-09-21       Impact factor: 10.793

Review 8.  Resolvin E1 as a novel agent for the treatment of asthma.

Authors:  Takeshi Hisada; Tamotsu Ishizuka; Haruka Aoki; Masatomo Mori
Journal:  Expert Opin Ther Targets       Date:  2009-05       Impact factor: 6.902

9.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Authors:  Kian Fan Chung; Sally E Wenzel; Jan L Brozek; Andrew Bush; Mario Castro; Peter J Sterk; Ian M Adcock; Eric D Bateman; Elisabeth H Bel; Eugene R Bleecker; Louis-Philippe Boulet; Christopher Brightling; Pascal Chanez; Sven-Erik Dahlen; Ratko Djukanovic; Urs Frey; Mina Gaga; Peter Gibson; Qutayba Hamid; Nizar N Jajour; Thais Mauad; Ronald L Sorkness; W Gerald Teague
Journal:  Eur Respir J       Date:  2013-12-12       Impact factor: 16.671

10.  Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation.

Authors:  Ourania Koltsida; Sergey Karamnov; Katerina Pyrillou; Thad Vickery; Aikaterini-Dimitra Chairakaki; Constantin Tamvakopoulos; Paschalis Sideras; Charles N Serhan; Evangelos Andreakos
Journal:  EMBO Mol Med       Date:  2013-04-15       Impact factor: 12.137
View more
  2 in total

1.  Gestational exposure to titanium dioxide, diesel exhaust, and concentrated urban air particles affects levels of specialized pro-resolving mediators in response to allergen in asthma-susceptible neonate lungs.

Authors:  Mohan Kumar; Naohiro Yano; Alexey V Fedulov
Journal:  J Toxicol Environ Health A       Date:  2021-11-21

2.  Novel Comprehensive Bioinformatics Approaches to Determine the Molecular Genetic Susceptibility Profile of Moderate and Severe Asthma.

Authors:  Hatem Zayed
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.